Gladman, D. D., Orbai, A., Gomez-Reino, J., Chang-Douglass, S., Leoncini, E., Burton, H. E., . . . Hsu, M. (2020). Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis. Curr Ther Res Clin Exp.
シカゴスタイル引用形Gladman, Dafna D., et al. "Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis." Curr Ther Res Clin Exp 2020.
MLA引用形式Gladman, Dafna D., et al. "Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis." Curr Ther Res Clin Exp 2020.
警告: この引用は必ずしも正確ではありません.